Profil
Ned Israelsen is the founder of Actavalon, Inc., CardioCreate, Inc., and Kalyra Pharmaceuticals, Inc. He previously worked as a Director at Kalyra Pharmaceuticals, Inc.
Postes actifs de Ned Israelsen
| Sociétés | Poste | Début |
|---|---|---|
CardioCreate, Inc.
 CardioCreate, Inc. BiotechnologyHealth Technology CardioCreate, Inc. develops cardiac stem cell therapies. Its stem cell therapies are used to repair and replace damaged heart tissues after a heart attack. The company was founded by Ned Israelsen, Stephen F. Flaim and Mark A. Sussman and is headquartered in San Diego, CA. | Fondateur | - |
Actavalon, Inc.
 Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Fondateur | - |
Anciens postes connus de Ned Israelsen
| Sociétés | Poste | Fin |
|---|---|---|
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Kalyra Pharmaceuticals, Inc.
Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Health Technology |
Actavalon, Inc.
Actavalon, Inc. Pharmaceuticals: MajorHealth Technology Actavalon, Inc. operates as a preclinical stage pharmaceutical company. It focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic and colon cancer among others. The company was founded by Ned Israelsen and Wesley G. Hatfield and is headquartered in San Diego, CA. | Health Technology |
CardioCreate, Inc.
CardioCreate, Inc. BiotechnologyHealth Technology CardioCreate, Inc. develops cardiac stem cell therapies. Its stem cell therapies are used to repair and replace damaged heart tissues after a heart attack. The company was founded by Ned Israelsen, Stephen F. Flaim and Mark A. Sussman and is headquartered in San Diego, CA. | Health Technology |
